San Antonio, TX, United States of America

Ian Clements

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Santalis Pharmaceuticals, Inc., Santalis Healthcare Corporation. Active years: 2017-2020.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ian Clements

Introduction

Ian Clements is a notable inventor based in San Antonio, TX, who has made significant contributions to the field of therapeutics. With a total of four patents to his name, Clements has focused on the applications of sandalwood oil in medical treatments.

Latest Patents

Clements' latest patents include innovative methods for using sandalwood oil to address oral mucositis. His research provides therapeutically effective compositions aimed at treating this painful condition. Additionally, he has developed methods for utilizing sandalwood oil to treat, prevent, or reduce the recurrence of clostridium infections, showcasing the versatility of this natural compound in medical applications.

Career Highlights

Throughout his career, Ian Clements has worked with reputable companies such as Santalis Pharmaceuticals, Inc. and Santalis Healthcare Corporation. His work in these organizations has allowed him to advance his research and contribute to the development of effective therapeutic solutions.

Collaborations

Clements has collaborated with professionals like Paul Castella and Corey Levenson, enhancing his research through teamwork and shared expertise.

Conclusion

Ian Clements stands out as an inventor whose work with sandalwood oil has the potential to impact the treatment of oral mucositis and clostridium infections. His contributions to the field of therapeutics are noteworthy and reflect his dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…